BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 34414077)

  • 1. Identification and validation of tumor microenvironment-related lncRNA prognostic signature for uveal melanoma.
    Liao CL; Hu N; Sun XY; Zhou Q; Tian M; Cao Y; Lyu HB
    Int J Ophthalmol; 2021; 14(8):1151-1159. PubMed ID: 34414077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N
    Liu Z; Li S; Huang S; Wang T; Liu Z
    Front Oncol; 2021; 11():704543. PubMed ID: 34395276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of co-expressed gene networks promoting CD8
    Zhang C; Xiao J; Fa L; Jiang F; Jiang H; Zhou L; Xu Z
    BMC Ophthalmol; 2023 Aug; 23(1):354. PubMed ID: 37563735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunogenic profiling of metastatic uveal melanoma discerns a potential signature related to prognosis.
    Wang J; Liu M; Sun J; Zhang Z
    J Cancer Res Clin Oncol; 2024 Jan; 150(1):23. PubMed ID: 38246894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploring the Prognostic Significance and Immunotherapeutic Potential of Single-Cell Sequencing-Identified Long Noncoding RNA (LncRNA) in Patients With Non-small Cell Lung Cancer.
    Chen L; Wang L; Xiong Z; Zhu X; Chen L
    Cureus; 2023 Nov; 15(11):e48436. PubMed ID: 38074028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significance of Aneuploidy in Predicting Prognosis and Treatment Response of Uveal Melanoma.
    Zhang X; Jin L; Zhou C; Liu J; Jiang Q
    Curr Med Chem; 2024 Mar; ():. PubMed ID: 38504568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic analysis and validation of lncRNAs in bladder cancer on the basis of neutrophil extracellular traps.
    Gu L; Guo H; Wu LX; Yuan JB
    J Gene Med; 2023 Oct; 25(10):e3525. PubMed ID: 37178049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive expression, prognostic and validation analysis of necroptosis-related lncRNAs in esophageal cancer.
    Duan X; Hou R; Huang Y; Wang C; Liu L; Du H; Shi J
    Transl Oncol; 2024 May; 46():101983. PubMed ID: 38797018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploring the potential mechanisms of Yi-Yi-Fu-Zi-Bai-Jiang-San therapy on the immune-inflamed phenotype of colorectal cancer via combined network pharmacology and bioinformatics analyses.
    Liu Y; Liang Y; Su Y; Hu J; Sun J; Zheng M; Huang Z
    Comput Biol Med; 2023 Nov; 166():107432. PubMed ID: 37729701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrating Single-cell and Bulk RNA-seq to Construct a Metastasis-related Model for Evaluating Immunotherapy and Chemotherapy in Uveal Melanoma.
    Du Y; Jiang X; Zhang Y; Ying J; Yi Q
    Curr Med Chem; 2024 Jan; ():. PubMed ID: 38173196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNAs KB-1836B5, LINC00566 and FAM27L are associated with the survival time of patients with ovarian cancer.
    Li H; Gong M; Zhao M; Wang X; Cheng W; Xia Y
    Oncol Lett; 2018 Sep; 16(3):3735-3745. PubMed ID: 30127984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LncRNA SNHG15 predicts poor prognosis in uveal melanoma and its potential pathways.
    Wu X; Li XF; Wu Q; Ma RQ; Qian J; Zhang R
    Int J Ophthalmol; 2020; 13(8):1195-1201. PubMed ID: 32821672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and validation of an immune-relevant risk signature predicting survival outcome and immune infiltration in uveal melanoma.
    Sun X; Li Q; Xu G
    Int Ophthalmol; 2023 Dec; 43(12):4689-4700. PubMed ID: 37688652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and validation of anoikis-related lncRNAs for prognostic significance and immune microenvironment characterization in ovarian cancer.
    Cao L; Zhang S; Peng H; Lin Y; Xi Z; Lin W; Guo J; Wu G; Yu F; Zhang H; Ye H
    Aging (Albany NY); 2024 Jan; 16(2):1463-1483. PubMed ID: 38226979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decoding the molecular landscape: A novel prognostic signature for uveal melanoma unveiled through programmed cell death-associated genes.
    Liu Z; Yu L; Lai J; Zhang R
    Medicine (Baltimore); 2024 May; 103(18):e38021. PubMed ID: 38701273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A centrosome-related gene signature for predicting the overall survival of uveal melanoma.
    Yu X; Guo X; Li W; Li J
    Transl Cancer Res; 2024 Feb; 13(2):771-781. PubMed ID: 38482432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel prognostic signature and potential therapeutic drugs based on tumor immune microenvironment characterization in breast cancer.
    Zhang Y; Zhou M; Sun J
    Heliyon; 2023 Oct; 9(10):e20798. PubMed ID: 37860520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive analysis of HOX family genes in endometrial cancer.
    Zhao L; Lou W; Zhang Y; Han Y; Zhang W
    Transl Cancer Res; 2023 Dec; 12(12):3728-3743. PubMed ID: 38192984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pyroptosis-related lncRNA prognostic signatures for cutaneous melanoma and tumor microenvironment status.
    Deng H; Chen Y; An R; Wang J
    Epigenomics; 2023 Jun; 15(12):657-675. PubMed ID: 37577979
    [No Abstract]   [Full Text] [Related]  

  • 20. Prognostic implications of tenascin C in peripheral blood and primary tumours at the time of uveal melanoma diagnosis.
    Herrspiegel C; Plastino F; André H; Stålhammar G
    Can J Ophthalmol; 2024 Jan; ():. PubMed ID: 38219791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.